•  
  •  
  •  
  •  

2025-10-01 21:51:24

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  AshapuriGoldOrnament

Stock Report

  • Strategic Expansion of Ashapuri Gold Ornament Limited into the North-East Indian Market
  • Ashapuri Gold Ornament Ltd receives order worth Rs. 11 crores
  • Ashapuri Gold Ornament Limited received orders worth Rs. 21 crores for Gold Jewellery
  • Ashapuri Gold Ornament Ltd Q2 FY2024-25 PAT rises to Rs. 3.44 crore
  • Ashapuri Gold Ornament Ltd receives order from Titan Company Limited
  • Ashapuri Gold Ornament Ltd Q1 FY2025 profit at Rs. 2.68 crore
  • Ashapuri Gold Ornament Ltd to participate in Preferred Manufacturers of India Show
  • Ashapuri Gold Ornament Ltd Q3FY24 net profit higher at Rs. 2.07 crore
  • Ashapuri Gold Ornament Ltd secures orders worth Rs. 100 crore at IIJS Premiere 2023
  • Ashapuri Gold Ornament Ltd Q1 FY2023-24 net profit at Rs. 47.30 lakhs
  • Ashapuri Gold Ornament Ltd fixes July 18, 2023 as record date for stock split
  • Ashapuri Gold Ornament Limited approves stock split
  • Ashapuri Gold Ornament Ltd Q4 FY2023 net profit at Rs. 2.65 lakhs
  • Ashapuri Gold Ornament Ltd Q1 FY2023 net profit higher at Rs. 1.25 crore
  • Ashapuri Gold Ornaments Ltd receives orders worth Rs. 30 crore in 'India Gem & Jewellery Exhibition' held in Mumbai
  • Ashapuri Gold Ornament Q3FY22 PAT up QoQ at Rs. 1.12 crore
  • Ashapuri Gold Ornament Ltd Q2FY22 profit up at Rs. 92.69 lakhs

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024